SCHOTT Pharmaceutical Packaging continues to experience growth in Russia and now plans to increase the production capacities at its plant in in Zavolzhe by more than 50 per cent, according to a company announcment at the recent Pharmtech trade fair in Moscow.
“Expanding our presence in Russia represents an important strategic step for the benefit of our customers,” emphasised Dr Jürgen Sackhoff, responsible for the Pharmaceutical Systems division of SCHOTT AG. “We are seeing continued growth in demand for locally manufactured primary packaging that also meets all of the international standards for quality. This will result in shorter delivery routes and better export opportunities for our customers. In other words, by pursuing a consistent investment strategy, we will be helping our customers in the Russian pharmaceutical industry to achieve their own growth and quality objectives,” he adds.
The Russian pharma industry has experienced double-digit growth in recent years. State initiatives like the government’s “Pharma 2020” strategy that seeks to encourage local manufacturing of high-quality medications according to the GMP standard will continue this development.
SCHOTT became the first international manufacturer in Russia to open a new GMP-compliant pharma packaging plant in the spring of 2011 and now the order situation has made it necessary to expand capacities earlier than expected. “Thanks to our many years of experience and high international standards for quality, SCHOTT is the right partner for the ambitious and growing Russian pharma industry,” Sackhoff adds.
Referring to the growing quality requirements of the Russian pharma industry. he concluded, “GMP will be required by law for all companies that manufacture in Russia starting in 2014 and SCHOTT has the necessary know-how on helping its customers to establish GMP-certified manufacturing thanks to its 125 years of experience and global manufacturing network.”
EP News Bureau – Mumbai
- Advertisement -
